Salbair B (200+100) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Lupin Laboratories Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Salbutamol, Beclomethasone. This drug comes in the form of Rotacap. The general packing available for this medicine consists of 30 Rotacap and is priced at Rs 30.3 (arround $0.4242 US Dollar)
Generic (Salt) Combination :
(Salbutamol+ Beclomethasone)
Pharma Company :
Lupin Laboratories Ltd.
Brand Label :
Salbair B (200+100)
Preparation Type :
Rotacap
Single Dose :
1 Rotacap
Composition (Fixed-Dose Combination) :
Salbutamol-200 mcg
Beclomethasone-100 mcg
Pack Size/Qty/Vol :
30 Rotacap
Price Unit :
Rs 1.01 INR (arround $0.01414 US Dollar)
Price Pack :
Rs 30.3 INR (arround $0.4242 US Dollar)
Drug details for Salbair B (200+100)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Salbair B (200+100) are :
Salbutamol-200 mcg
Beclomethasone-100 mcg
Salbutamol Indication (Prescribed for or used as): Reversible airways obstruction. Premature labour.
For more details on Salbutamol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Salbutamol..
Beclomethasone Indication (Prescribed for or used as): Eczema, psoriasis, otitis externa. Lichen simplex and planus, Anal and vulval pruritus. Contact dermatitis. Seborrhoeic dermatitis.
For more details on Beclomethasone, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Beclomethasone..
Salbair B (200+100) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 4 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Salbair B (200+100), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Salbutamol-200 mcg Beclomethasone-100 mcg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.